Stock Events

Stock Events

Avenue Therapeutics 

$0.3
28
-$0.05-14.29% Thursday 17:59

Statistics

Day High
0.41
Day Low
0.41
52W High
0.97
52W Low
0.15
Volume
40
Avg. Volume
6,404
Mkt Cap
955,200
P/E Ratio
0.28
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q4 2025
Next
-6.43
-4.48
-2.52
-0.57
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-23.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATXI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing in the pain management market where Avenue Therapeutics also operates.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment, competes in developing treatments for pain management, directly competing with Avenue's focus.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in the chronic pain treatment market with its portfolio of pain management drugs, overlapping with Avenue Therapeutics' interests.
Pfizer
PFE
Mkt Cap140.15B
Pfizer offers a range of products for pain management, making it a competitor in the same therapeutic area as Avenue Therapeutics.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. has a diverse portfolio that includes pain management solutions, positioning it as a competitor.
Novartis
NVS
Mkt Cap237.61B
Novartis AG, with its broad range of medicines, including those for pain management, competes in the same space as Avenue Therapeutics.
Pacira BioSciences
PCRX
Mkt Cap997.06M
Pacira BioSciences, Inc. is known for its non-opioid pain management and surgical care products, competing in the same market as Avenue Therapeutics.

About

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Show more...
CEO
Dr. Alexandra MacLean M.D.
Employees
2
Country
US
ISIN
US05360L4032

Listings

OTC Link
US
ATXI

0 Comments

Share your thoughts

FAQ

What is Avenue Therapeutics stock price today?▼
The current price of ATXI is $0.3 USD — it has decreased by -14.29% in the past 24 hours. Watch Avenue Therapeutics stock price performance more closely on the chart.
What is Avenue Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Avenue Therapeutics stocks are traded under the ticker ATXI.
Is Avenue Therapeutics stock price growing?▼
ATXI stock has risen by +7.2% compared to the previous week, the month change is a +12.23% rise, over the last year Avenue Therapeutics has showed a +15.3% increase.
What is Avenue Therapeutics market cap?▼
Today Avenue Therapeutics has the market capitalization of 955,200
When is the next Avenue Therapeutics earnings date?▼
Avenue Therapeutics is going to release the next earnings report on May 13, 2026.
What is Avenue Therapeutics revenue for the last year?▼
Avenue Therapeutics revenue for the last year amounts to 0 USD.
What is Avenue Therapeutics net income for the last year?▼
ATXI net income for the last year is -23.3M USD.
How many employees does Avenue Therapeutics have?▼
As of April 04, 2026, the company has 2 employees.
In which sector is Avenue Therapeutics located?▼
Avenue Therapeutics operates in the Health Care sector.
When did Avenue Therapeutics complete a stock split?▼
The last stock split for Avenue Therapeutics was on April 26, 2024 with a ratio of 1:75.
Where is Avenue Therapeutics headquartered?▼
Avenue Therapeutics is headquartered in Bay Harbor Islands, US.